404 related articles for article (PubMed ID: 12368140)
1. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.
Agoşton-Coldea L; Rusu LD; Zdrenghea D; Rusu ML; Pop D; Crăciun A; Poanta L; Gatfossé M; Rosenstingl S; Mocan T
Rom J Intern Med; 2008; 46(2):137-44. PubMed ID: 19284085
[TBL] [Abstract][Full Text] [Related]
3. [Apolipoprotein E and angiotensin-converting enzyme gene polymorphisms as risk factors of coronary disease].
Bennouar N; Allami A; Laraqui A; Azeddoug H; El-Kadiri N; Benkouka F; Bendriss A; Ghannam R; Benomar A; Fellat S; Benomar M
Ann Biol Clin (Paris); 2004; 62(3):295-304. PubMed ID: 15217762
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
[TBL] [Abstract][Full Text] [Related]
5. [Association between lipoprotein(a) and coronary disease].
Bovet P; Burnand B; Kappenberger L; Riesen W; Darioli R
Schweiz Med Wochenschr; 1993 Nov; 123(45):2138-46. PubMed ID: 8266034
[TBL] [Abstract][Full Text] [Related]
6. [Detection of serum Lp(a) level of coronary heart disease and its clinical significance].
Liang XH; Huang CZ
Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):227-8. PubMed ID: 12536688
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) and coronary heart disease in Indian population.
Singh S; Dwivedi S; Melkani GC; Rani C; Gaur SP; Mandal SK; Mahua J
J Assoc Physicians India; 1999 Dec; 47(12):1157-60. PubMed ID: 11225215
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) in coronary heart disease: a case-control study.
Gupta R; Kastia S; Rastogi S; Kaul V; Nagar R; Enas EA
Indian Heart J; 2000; 52(4):407-10. PubMed ID: 11084780
[TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
11. [Lipoprotein(a) as a biochemical marker of coronary atherosclerosis].
Ezhov MV; Afanas'ev OI; Benevolenskaia GF; Savchenko AP; Liakishev AA; Pokrovskiĭ SN
Ter Arkh; 1997; 69(9):31-4. PubMed ID: 9411822
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) as a marker of coronary artery disease and its association with dietary fat.
Burman A; Jain K; Gulati R; Chopra V; Agarwal DP; Vasisht S
J Assoc Physicians India; 2004 Feb; 52():99-102. PubMed ID: 15656041
[TBL] [Abstract][Full Text] [Related]
13. [Lipoprotein (a). A new risk factor for coronary artery disease].
Rim L; Ali B; Slim BA; Bechir Z
Tunis Med; 2000 Nov; 78(11):648-52. PubMed ID: 11155388
[TBL] [Abstract][Full Text] [Related]
14. [Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients].
Blacher J; Montalescot G; Ankri A; Chadefaux-Vekemans B; Benzidia R; Grosgogeat Y; Kamoun P; Thomas D
Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1241-6. PubMed ID: 8952820
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of risk factors for coronary heart disease].
Jin YP; Qin GM; Zhang SZ; Li CJ; Xu G
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):98-101. PubMed ID: 12839659
[TBL] [Abstract][Full Text] [Related]
16. [Homocysteinemia and coronary artery disease: a case-control study in a Tunisian population].
Souissi M; Feki M; Mourali S; Enneifer M; Omar S; Sanhaji H; Mechmeche R; Mebazaa A; Kaabachi N
Arch Mal Coeur Vaiss; 2006 Sep; 99(9):781-5. PubMed ID: 17067095
[TBL] [Abstract][Full Text] [Related]
17. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
18. Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.
Balogh E; Bereczky Z; Katona E; Koszegi Z; Edes I; Muszbek L; Czuriga I
Thromb Res; 2012 Feb; 129(2):133-8. PubMed ID: 21803402
[TBL] [Abstract][Full Text] [Related]
19. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
20. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
